These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [HORMONAL STUDY OF PROGRESSIVE DUCHENNE MYOPATHY. I. ANDROGENS AND CORTICOIDS]. HERSCHBERG AD; COIRAULT R; GIBOUDEAU J Ann Endocrinol (Paris); 1964; 25():529-34. PubMed ID: 14208639 [No Abstract] [Full Text] [Related]
7. Anabolic steroids in the management of muscular dystrophy. Charash L Pediatrics; 1965 Sep; 36(3):402-5. PubMed ID: 5829332 [No Abstract] [Full Text] [Related]
8. [The use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy]. BEKENY G; KRAFT F; LANG S Nervenarzt; 1960 Mar; 31():118-23. PubMed ID: 13798372 [No Abstract] [Full Text] [Related]
9. [Use of durabolin (19-nor-androstenolone phenylpropionate) in the therapy of progressive muscular dystrophy]. BEKENY G; KRAFT F; LANG S Orv Hetil; 1960 Feb; 101():229-34. PubMed ID: 13798373 [No Abstract] [Full Text] [Related]
10. [Combined use of anabolic steroids and digitoxin in progressive muscular dystrophy]. Yamamoto H; Sugita H; Furukawa T Iryo; 1966 Jul; 20(7):704-8. PubMed ID: 5981771 [No Abstract] [Full Text] [Related]
11. CLINICAL EVALUATION OF AN ORAL ANABOLIC STEROID (METHANDROSTENOLONE, DIANABOL CIBA) IN CHILDREN WITH MUSCULAR WEAKNESS AND WASTING. GAMSTORP I Acta Paediatr (Stockh); 1964 Nov; 53():570-7. PubMed ID: 14225883 [No Abstract] [Full Text] [Related]
12. TREATMENT OF MUSCULAR DYSTROPHY WITH A NUCLEOTIDES- NUCLEOSIDES COMBINATION. GUEST KE; MCLAY WD Br J Clin Pract; 1964 Jul; 18():395-400. PubMed ID: 14196785 [No Abstract] [Full Text] [Related]
13. REDUCTION OF SERUM TRIGLYCERIDES IN PATIENTS TREATED WITH SODIUM D-THYROXINE. FELDMAN EB; CARTER AC Metabolism; 1963 Dec; 12():1132-40. PubMed ID: 14100284 [No Abstract] [Full Text] [Related]
14. [EXPERIMENTAL DIGITOXIN POISONING AND SERUM ENZYMES. ON THE BEHAVIOR OF CREATINE PHOSPHOKINASE (CPK)]. ATHANASIOU DJ; TSIRIMBAS A Z Gesamte Exp Med; 1964 Apr; 138():116-20. PubMed ID: 14208909 [No Abstract] [Full Text] [Related]
15. [Effect of neosteron on creatine excretion in muscular dystrophy]. BACH I; FELIX J; GARAS Z; KOMOR K; POPPER Z Magy Belorv Arch (1955); 1955 Aug; 8(4):106-8. PubMed ID: 13287290 [No Abstract] [Full Text] [Related]
16. ACETYL DIGITOXIN IN CONGESTIVE CARDIAC FAILURE. (A COMPARATIVE STUDY OF 40 CASES). SHAH AV; NAIK CH Indian Heart J; 1965 Apr; 17():137-46. PubMed ID: 14336146 [No Abstract] [Full Text] [Related]
17. PI-5 SPECIFICITY IN DIGITOXIN TOXICITY: A CASE REPORT. GIBSON HC; SMITH DM; ALPERN M Arch Ophthalmol; 1965 Aug; 74():154-8. PubMed ID: 14318486 [No Abstract] [Full Text] [Related]
18. A study of the treatment of dystrophia musculorum progressiva with an anabolic steroid: nor-androstenolone decanoate. PATEISKY K; SCHINKO H; HABERLER H Acta Endocrinol Suppl (Copenh); 1961; 39(Suppl 63)():185-98. PubMed ID: 14484294 [No Abstract] [Full Text] [Related]
19. EFFECT OF DIGITALIS GLUCOSIDES ON ELECTROCARDIOGRAM AND EXERCISE TEST IN HEALTHY SUBJECTS. NORDSTROEM-OHRBERG G Acta Med Scand Suppl; 1964; 420():SUPPL 420:1-75. PubMed ID: 14163425 [No Abstract] [Full Text] [Related]
20. [DETERMINATION OF CREATINE PHOSPHOKINASE IN THE BLOOD SERUM OF PATIENTS WITH PROGRESSIVE MUSCULAR DYSTROPHY]. GRINIO LP; KONSISTORUM AV Vopr Med Khim; 1964; 10():70-3. PubMed ID: 14207496 [No Abstract] [Full Text] [Related] [Next] [New Search]